Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2.
Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, in particular atrial and ventricular arrhythmias[1].
[1]. Bj?re, Annika, et al. NEW OXABISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS. WO 2001028992 A2.
















